Department of Psychiatry, Henan Key Lab of Biological Psychiatry, International Joint Research Laboratory for Psychiatry and Neuroscience of Henan of Xinxiang Medical University, Henan Collaborative Innovation Center of Prevention and treatment of mental disorder, The Second Affiliated Hospital of Xinxiang Medical University (Henan Mental Hospital), Xinxiang, 453002, China.
College of Medical Engineering, Xinxiang Medical University, Xinxiang, 453003, China.
Curr Treat Options Oncol. 2024 Oct;25(10):1283-1288. doi: 10.1007/s11864-024-01265-6. Epub 2024 Oct 2.
Leukemia is a type of hematological malignancy (HM) caused by uncontrolled proliferation, apoptosis, and differentiation of hematopoietic stem cells (HSCs). Leukemia cells proliferate greatly in the bone marrow (BM), infiltrate other tissues and organs, and affect the normal hematopoietic function. Although the emergence of new targeted agents and immune agents has improved the prognosis of patients, due to the complex pathogenic factors and heterogeneity of leukemia, there are still some patients with poor prognosis. Recent studies have shown that silent information regulator 1 (SIRT1) is involved in the proliferation, apoptosis, metabolism, and senescence of leukemia cells. As a double-edged sword in leukemia cells, SIRT1 can both promote and inhibit the growth of leukemia cells. Since its mechanism of action has not been elucidated, it is urgent to explore the regulatory mechanism of SIRT1 in leukemia. In this review, we discussed the mechanisms of SIRT1 in different aspects of leukemia, providing a theoretical basis for the treatment of patients with leukemia.
白血病是一种由造血干细胞(HSCs)不受控制的增殖、凋亡和分化引起的血液系统恶性肿瘤(HM)。白血病细胞在骨髓(BM)中大量增殖,浸润其他组织和器官,并影响正常的造血功能。尽管新的靶向药物和免疫制剂的出现改善了患者的预后,但由于白血病的发病因素复杂和异质性,仍有一些患者预后不良。最近的研究表明,沉默信息调节因子 1(SIRT1)参与白血病细胞的增殖、凋亡、代谢和衰老。作为白血病细胞中的双刃剑,SIRT1 既能促进又能抑制白血病细胞的生长。由于其作用机制尚未阐明,因此迫切需要探索 SIRT1 在白血病中的调节机制。在这篇综述中,我们讨论了 SIRT1 在白血病不同方面的作用机制,为白血病患者的治疗提供了理论依据。